Pan's Ink and Michigan Hemp Company on Tuesday announced they have entered into a strategic supply agreement through which Pan's Ink will provide tailored, natural terpene mixtures in bulk to Michigan Hemp Company for use in MHC's hemp CBD products. Pan's Ink will distribute its terpene mixtures to MHC under the Pan's Ink brand, TerpAid™.
Terpenes are an essential part of hemp and cannabis medicine, just as are the cannabinoids, including cannabidiol (CBD). These aromatic compounds work in concert to promote healing and well being through the "entourage effect."
Pan's Ink is known in the legal cannabis, smoking accessories, and aromatherapy industries for its line of terpene customization products. These products are used by customers to target the effects of their legal cannabis or other herbal smoking products in order to provide consistent symptom relief.
Pan's Ink also supplies balanced terpene profiles in bulk form to manufacturers. "We are thrilled to be working with hemp pioneers Joe Brown and the Michigan Hemp Company in this new venture," said Jack Turner, CEO and Founder of Pan's Ink.
"Terpenes are an integral part of cannabis medicine, and our 100 percent natural terpenes are the best in the industry," Turner said. "Teaming up with Michigan Hemp Company will gain Pan's Ink a valuable new relationship and will allow Michigan Hemp Company to augment its already cutting-edge products."
Researchers announce that clinical trials involving anti-convulsive form of marijuana is showing "promise" in children
As promising results from clinical trials are announced in the use of medicinal cannabis (medical marijuana) to treat intractable epilepsy, those lawfully cultivating the plant in California are being raided by local law enforcement. Two gardens destroyed by police in the past two months in Mendocino County and Modesto contained a rare strain of medical marijuana rich in Cannabidiol (or CBD) used by children many of whom do not respond to other drug treatments.
On August 5, unidentified men in camouflage dropped from an unmarked helicopter onto the 120-acre property of Potter Valley resident and cancer survivor Susan Schindler, cutting down her lawfully cultivated medical marijuana plants. In addition to growing for herself, Schindler was cultivating rare strains of medical marijuana rich in CBD, a non-psychotropic constituent of the plant, which were being used orally by children with epilepsy.
Schindler was also cultivating plants rich in THCV, another active constituent (or cannabinoid) that was producing positive results for a patient with Parkinson's disease.
Pioneers in cultivating CBD (cannabidiol) genetics for over two years, Exhale Med Center, the #1 rated medical marijuana shop on Yelp, carries one of the rarest strains of CBD-rich cannabis found today, called “CBD Web.” This strain contains 16 percent CBD to 2 percent THC, a ratio high enough to comfort the parents of a sick child suffering from epilepsy, giving them the confidence that the child will not feel high while reaping the medicinal rewards.
CBD Web is a constant at Exhale Med Center, in addition to three variations of CBD-rich strain genetics, CBD edibles, tinctures, creams, Rick Simpson Oils, and many different forms of concentrates. With last year's release of Dr. Sanjay Gupta's CNN Special Weed, a demand has been created for highly concentrated CBD products that will help patients’ symptoms without giving them a psychoactive high.
Known as one of the elite shops in Los Angeles, Exhale Med Center is a Prop D compliant, “Pre-ICO,” medical marijuana pioneer, offering one of the best selections of strain variations in town, in every price range. From high-end indoor sativas and hybrids from the Bay Area and top shelf indicas from SoCal to the outdoor and green house varieties from Northern California’s ‘Emerald Triangle’, Exhale says its range of more than 50 strains offers a quality remedy for most ailments. This December will mark their first year anniversary in their new zone-compliant location at 980 North La Cienega Blvd, Suite 102, Los Angeles, CA 90069.
By Steve Elliott
South Carolina lawmakers earlier this year passed one of those "CBD only" bills that allow parents to possess cannabidiol oil, derived from the marijuana plant, for treatment of epileptic seizures. But CBD oil can't be legally made in South Carolina, and it's against federal law to transport it across state lines, so a new Medical Marijuana Study Committee is working out the details of how, exactly, to implement their new law.
That committee met for the first time on Wednesday at the South Carolina Statehouse in Columbia, reports Robert Kittle at WSPA.
CBD oil doesn't have the mind-altering effects of tetrahydrocannabinol (THC), the which gets users high. As written, South Carolina's CBD-only law is just for patients in a clinical trial to treat epilepsy, and it provides no way for them to legally obtain the oil.
Janel Ralph of Myrtle Beach, whose five-year-old daughter Harmony has lissencephaly, which causes seizures, wants the law expanded so that it's not just a clinical trial and not just for epilepsy. She said the law, as written, doesn't really help.
"You're saying you can get it," she said. "You're saying you can give it to your child, and yes we're going to let you do this. But then they're not giving you any way to actually get it legally."
By Steve Elliott
Oklahoma Governor Mary Fallin on Wednesday announced she wants to work with lawmakers in the next session of the Legislature to legalize cannabidiol oil (CBD) on a limited, medically supervised, trial-only basis.
CBD is a component of the marijuana plant; unlike THC (tetrahydrocannabinol), it does not produce a high. The compound has shown effectiveness in quelling seizures in toddlers with epilepsy and other conditions. The CBD oil isn't smoked; it is not considered a recreational drug.
"I do not support legalizing the recreational use of marijuana," Fallin said, reports Laura Noland at KFOR-TV. "Nor do I support a broadly defined 'medicinal' marijuana use that makes it easy for healthy adults and teenagers to find and buy drugs."
"I do support allowing potentially life-saving medicine to find its way to children in need," the Republican Governor said. "I am very interested in allowing limited, heavily supervised use of non-intoxicating CBD to be delivered on a trial basis to sick children in Oklahoma."
Rep. Jon Echols is preparing to lead a legislative study of allowing medical trials for CBD in treating children affected by severe seizures. Echols said he decided to take on the issue when his niece was told CBD may help with her medical condition.
The Herban Legends Collective scholarship fund announced on Monday that it has received a donation of CBD-rich tincture from LeBlanc CNE.
Located in White Center, Seattle, Washington, Herban Legends in a prepared statement said it has "a strong commitment to making medical marijuana available to as many patients as possible."
LeBlanc CNE is a grower and broker of medical cannabis with a firm belief that healthcare is a right, not a privilege. To that end, LeBlanc tithes itself and donates medical cannabis to Herban Legends.
LeBlanc's most recent donation was of a tincture, Batch #5, rich in cannabidiol (CBD), the non-psychoactive compound responsible for many of marijuana's healing effects.
CBD has been used with children suffering from seizures, PTSD, Crohn's disease, chronic pain, and a number of other conditions.
"LeBlanc is proud to support Herban Legend Collective's goal of bringing medical marijuana to an otherwise underserved neighborhood," said Jerry Whiting, founder of LeBlanc CNE. "How can anyone say ‘no' to alleviating the pain and suffering of others?"
According to Whiting, Batch #5 is an alcohol-based tincture made with cannabis strains like Harlequin and Cannatonic, as opposed to strains of marijuana high in THC favored by recreational users.
Batch #5 was made using 190-proof Everclear. LeBlanc CNE said its whole plant extraction method captured a wide range of cannabinoids and terpenes.
By Steve Elliott
Missouri Governor Jay Nixon on Monday signed legislation into law that allows the use of cannabidiol oil extracted from marijuana to treat epileptic seizures that can't be effectively treated by pharmaceuticals.
The legislation was sponsored by state Sen. Eric Schmitt (R-St. Louis County), whose 9-year-old son has epilepsy, reports the Associated Press.
Patients and parents who want to use CBD oil will be required to register with the Missouri Department of Health, and also have a neurologist verify that the patient's epilepsy hasn't responded to at least three other treatments. (Why on earth would they only use the most effective and least toxic option when all the others have been exhausted?)
When asked what all the Missouri families who had moved to Colorado for legal access to CBD oil should do, Gov. Nixon replied, "Move back to Missouri."
When pressed on the question of whether such families would be prosecuted, Gov. Nixon said, "It would be better to talk to the attorney general's office about that. All I know is the measure I signed today will help us move forward to make sure Missouri can provide these therapies to families in need."
The Truth About CBD
By Steve Elliott
The North American trade group Hemp Industries Association has published its position on what it called the misbranding of cannabidiol (CBD) products as "hemp oil." The new statement from HIA explains the difference between hemp oil and CBD extracts in terms of their respective uses and means of production, and emphasizes the need for accurate language in the marketplace so consumers aren't misled.
"Hemp oil is the common term for hempseed oil, obtained by pressing hemp seeds that contain low levels of CBD, typically less than 25 parts per million (ppm)," the position states. "In contrast, CBD extracts are produced either directly from cannabis flowers that are up to 15 percent CBD (150,000 ppm), or indirectly as a co-product of the flowers and leaves that are mixed in with the stalks during hemp stalk processing for fiber."
The Drug Enforcement Administration attempted to ban important and commerce of hempseed and oil food products in 2001, claiming these products were Schedule I controlled substances. However, HIA successfully sued the CDEA, unequivocally establishing hemp seed, oil, and protein as entirely legal to import, process, sell and consume in the United States.
By Steve Elliott
Two months after Wisconsin Governor Scott Walker signed into a law a measure allowing the use of cannabidiol (CBD) oil, a marijuana derivative used to quell seizures without getting patients high, nobody has yet been able to access the medicine.
The bad situation is due at least in part because of obstacles foolishly written into the legislation at the last minute, reports Dana Ferguson at the Journal Sentinel.
"It is frustrating," said Amylynne Santiago Volker of the roadblocks between her nine-year-old son, Nicholas, and the experimental treatment. "It's there in paper, but we can't access it."
Unfortunately, Wisconsin's "CBD-only" law appears as useless as most of the rest passed recently by state legislatures who want to be seen as "doing something" in the face of overwhelming popular support for medicinal cannabis, without having the courage to pass an actual medical marijuana law which could help actual patients.
Gov. Walker on Friday told reporters he "wasn't sure" if his administration could do anything to free up access to CBD, but if more could be done through state legislation, Walker claimed he was "committed to working with lawmakers" to do so.
Two Northern California medical marijuana dispensaries have announced they will be giving away free high-CBD tincture medication for children suffering from seizure disorders.
In the wake of the recent death of 6-year old Charlee Nelson in Utah after she was denied cannabis extract known to help control seizures caused by a neurological disorder, Dave Spradlin, co-director of Magnolia Wellness in Oakland and River City Phoenix in Sacramento, has announced that he will provide for free the expensive extract to any patients with a similar ailment.
The medicine is a scientifically produced liquid made from marijuana plants and used to treat people with severe seizure disorders. The tincture is rich in a chemical called cannabidiol, or CBD, but low in THC, the main psychoactive ingredient in marijuana.
CBD is a non-psychoactive component of marijuana that is known to possess a wide range of therapeutic benefits. It has proven to be especially effective in the treatment of seizures brought on by neurological conditions such as Batten disease, which was blamed in the death of Charlee Nelson.
“People are really suffering and this product has been known to cut seizures from hundreds a day to just a few a week or none at all,” said Spradlin.
Many in the medical community feel this is an effective alternative to conventional pharmaceuticals and can dramatically improve a patient’s quality of life.
By Steve Elliott
Parents in Pennsylvania who want to treat their children's seizures with a marijuana derivative were hopeful after Governor Tom Corbett announced last month he could support a medical study of cannabidiol (CBD). But the program can't begin until the state's House Republican majority supports the move -- and timid GOP party leaders are opposing it, despite the fact that legislatures in states as conservative as Alabama and Mississippi have approved similar legislation.
A majority of GOP members of the House still oppose such a study, according to a spokesman,and don't support authorizing Gov. Corbett's plan to allow children with intractable seizures who are not helped by standard therapies to have supervised access to cannabidiol (CBD), a component of marijuana that does not produce a high, reports Karen Langley at the Pittsburgh Post-Gazette.
The Republican state representatives said they believe the U.S. Food and Drug Administration (FDA) -- not the states -- should decide what is medicine, according to spokesman Steve Miskin, putting the lie to GOP claims of supporting "states' rights."
"That is where the majority of members of our caucus stand," claimed the apparently cold-hearted Miskin. "They do not believe the state should approve pot -- marijuana -- of any sort. At this moment there are no plans to move any type of legislation to legalize the use of any derivative of marijuana."
By Steve Elliott
Iowa Governor Terry Branstad said he will sign a bill legalizing the use of cannabidiol oil (CBD oil), a non-psychoactive concentrate derived from marijuana.
Families with kids suffering from epilepsy went to Iowa legislators this year asking for their help, reports KWWL.
At first, Gov. Branstad opposed the plan, claiming he was worried about "unintended consequences" like "drug abuse." The Governor didn't explain how legalizing a substance which doesn't get anyone high would do that.
The Governor claimed he "had empathy" for families who believe CBD helps quell seizures. But he still fretted over signing the bill.
"I think it would be a mistake to look at now expanding it to a whole bunch of other things," Branstad said, reports AP, evidently believing the suffering of epilepsy patients is somehow more deserving of relief than that of patients with other maladies. "I think we need to look at this as a very careful experiment that we and other states like Utah and Alabama are doing and see if it really does have the efficacy that the families hope it has."
The therapeutic potential of medical marijuana and pure cannabidiol (CBD), an active substance in the cannabis plant, for neurologic conditions is being debated in the scientific and medical communities -- as well as in the popular press. A series of articles published in the current issue ofEpilepsia, a journal of the International League Against Epilepsy (ILAE), examines the potential use of medical marijuana and CBD in treating severe forms of epilepsy such as Dravet syndrome.
In a case study, Dr. Edward Maa, chief of the Comprehensive Epilepsy Program at Denver Health in Denver, Colorado, details one mother’s experience of providing medical marijuana to her child with Dravet syndrome. The adjunct therapy, with a higher cannabidiol/D9-tetrahydrocannabinol (CBD:THC) ratio in the strain of cannabis, now known as Charlotte's Web, was given in conjunction with the patient’s antiepileptic drug regimen.
The child’s seizure frequency was reduced from 50 convulsions per day to two to three nighttime convulsions per month.
“Colorado is 'ground zero' of the medical marijuana debate,” said Dr. Maa. “As medical professionals it is important that we further the evidence of whether CBD in cannabis is an effective antiepileptic therapy.”
Currently, 21 states and the District of Columbia (DC) have legalized marijuana for medical purposes.
By Steve Elliott
Florida Governor Rick Scott, running for reelection in November, on Thursday said he would sign legislation allowing a non-psychoactive medical marijuana extract low in THC but high in CBD to treat children and other patients suffering from seizures.
Despite his firm opposition to an actual medical marijuana law, Gov. Scott said he would sign the so-called Charlotte's Web bill, which passed the Republican-controlled House with bipartisan support on Thursday, reports Andrew Perez at The Huffington Post.
Charlotte's Web is one of many high-CBD strains of marijuana, but in a development that undoubtedly makes the Stanley Brothers of Colorado very happy (and quite rich), it seems to be the one that gets all the media attention. Ill-informed state lawmakers such as those in Florida who want to appear to care about patients, and of course want to therefore get a lot of votes, know just enough about medical marijuana to have maybe watched Dr. Sanjay Gupta's "Weed" specials, and they learned from it, or from second-hand accounts of the show, that "Charlotte's Web" doesn't get kids stoned and helps quell seizures.
So then they pass restrictive legislation, sometimes even requiring the specific strain, Charlotte's Web, which enriches the Stanley Brothers while leaving out in the cold other high-CBD strains such as Cannatonic and Harlequin.
By Steve Elliott
The Wisconsin Senate is expected to vote Tuesday on a bill which would legalize a marijuana byproduct, cannabidiol oil, that doesn't make users high, but may relive seizure disorders in children.
The CBD oil bill falls well short of legislation to legalize medical marijuana, reports Jason Stein of the Milwaukee Journal Sentinel, legalizing only one cannabinoid from the plant. The Wisconsin Assembly last week approved the CBD bill on a voice vote, sending it to the Senate.
The bill was moved out of the Senate Health Committee on Thursday, where Chairwoman Sen. Leah Vukmir (R-Wauwatosa) tried to block it from being voted upon because she opposes the legislation. The proposal was instead placed in a committee where it could be scheduled for a floor vote in the Senate's last session on Tuesday, April 1.
The bill would go to the desk of Republican Gov. Scott Walker if passed by the Senate.
Rep. Robb Kahl (D-Monona) sponsored the CBD oil bill after a constituent, Amylynne Volker, told him about her son, Nic, who has about 100 epileptic seizures per day. "God bless them!" Volker said, when she learned the measure is poised to move forward.
Volker said the good news was a great way to celebrate her birthday on Friday. "It's pretty incredible and awesome," she said. "It's almost the best birthday present I could get." She said she already had a doctor in mind if the bill passes.